Chembio Diagnostics, Inc.

We are a leading POC diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted and fever diseases.

[Chembio Diagnostics, Inc. @ChembioDx]

Unlike traditional lateral flow formats, Chembio’s patented 𝗗𝘂𝗮𝗹 𝗣𝗮𝘁𝗵 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 (𝗗𝗣𝗣®) technology separates sample flow from conjugate flow — designed to support improved sensitivity and multiplex testing.
https://t.co/HEZCK3y7pu

#BioSynexUS #Chembio

[Chembio Diagnostics, Inc. @ChembioDx]

𝗝𝘂𝗻𝗲 𝗶𝘀 𝗠𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗠𝗼𝗻𝘁𝗵—a reminder that accessible diagnostic testing plays an important role in supporting proactive healthcare and patient engagement.

Learn more about STAT-PAK®: https://t.co/whRDkFBDoY

#BioSynexUS #Chembio #MensHealthMonth #STATPAK

[Chembio Diagnostics, Inc. @ChembioDx]

The 𝗗𝗣𝗣® 𝗛𝗜𝗩-𝗦𝘆𝗽𝗵𝗶𝗹𝗶𝘀 𝗔𝘀𝘀𝗮𝘆 enables simultaneous detection of both biomarkers from a single fingerstick blood sample, delivering results in approximately 15 minutes.

Learn how to implement multiplex testing today: https://t.co/UgWmKs92H4

#BioSynexUS #Chembio

[Chembio Diagnostics, Inc. @ChembioDx]

The Chembio SURE CHECK® HIV 1/2 Assay is designed specifically to simplify point-of-care testing in high-impact settings. Deliver accurate testing anywhere it’s needed. Learn how to elevate your outreach: https://t.co/VZRNCIr6XH

#BioSynexUS #Chembio #SureCheckHIV

[Chembio Diagnostics, Inc. @ChembioDx]

In community healthcare settings, every patient visit matters. Streamline your clinic’s workflow. Learn more about the The DPP® HIV-Syphilis Assay: https://t.co/n97qBYobg5

#BioSynexUS #Chembio #NationalNursesMonth #HIVTesting #SyphilisAwareness #PublicHealth #PointOfCare

[Chembio Diagnostics, Inc. @ChembioDx]

This National Nurses Month, we salute the nurses taking high-quality care into the heart of our communities.

See how decentralized testing is changing the landscape of care: https://t.co/1xCCgj0cwi

#BioSynexUS #Chembio #NationalNursesMonth #PublicHealth #PointOfCare

[Chembio Diagnostics, Inc. @ChembioDx]

As we celebrate National Nurses Month, we recognize the nurses who are evolving their workflows to ensure no patient is left without an answer.

Learn about our Chembio’s rapid STI products at: https://t.co/1xCCgj0cwi

#BioSynexUS #Chembio #NationalNursesMonth #PublicHealth

[Chembio Diagnostics, Inc. @ChembioDx]

On National Women’s Health Week, the focus is on more than just annual exams—it’s about proactive, comprehensive care. Discover why the DPP® HIV-Syphilis Assay is the premier choice for rapid diagnostic STI testing: https://t.co/n97qBYobg5 #BioSynexUS #Chembio #WomensHealth

[Chembio Diagnostics, Inc. @ChembioDx]

𝗪𝗲’𝗿𝗲 𝗶𝗻 𝗢𝗿𝗹𝗮𝗻𝗱𝗼 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗠𝗰𝗞𝗲𝘀𝘀𝗼𝗻 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝗮𝗹𝗲𝘀 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲. We're proud to be on-site connecting with the McKesson team. Stop by Booth #934!
#BioSynexUS #Chembio #Qualigen #McKesson #NationalSalesConference #PointOfCare

[Chembio Diagnostics, Inc. @ChembioDx]

𝗝𝗼𝗶𝗻 𝘂𝘀 𝗳𝗼𝗿 𝗮𝗻 𝘂𝗽𝗰𝗼𝗺𝗶𝗻𝗴 𝗗𝗜𝗔𝗟𝗦 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗳𝗼𝗰𝘂𝘀𝗲𝗱 𝗼𝗻 𝗽𝗼𝗶𝗻𝘁-𝗼𝗳-𝗰𝗮𝗿𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀��𝗶𝗰𝘀 𝗳𝗼𝗿 𝗛𝗜𝗩 𝗮𝗻𝗱 𝘀𝘆𝗽𝗵𝗶𝗹𝗶𝘀.

Register here: https://t.co/WS518IuJrP

#BioSynexUS #Chembio #PublicHealth #STIDiagnostics #PointOfCare

[Chembio Diagnostics, Inc. @ChembioDx]

HIV and syphilis continue to rise in many communities — and co-infection is common. Testing for both shouldn’t require multiple visits, multiple samples, or missed opportunities.

Learn more about the DPP® HIV-Syphilis Assay:
https://t.co/UgWmKs92H4

#BioSynexUS #Chembio #HIV

[Chembio Diagnostics, Inc. @ChembioDx]

𝗪𝗲’𝘃𝗲 𝗯𝗿𝗼𝘂��𝗵𝘁 𝗿𝗮𝗽𝗶𝗱 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗡𝗲𝘄 𝗢𝗿𝗹𝗲𝗮𝗻𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗡𝗖𝗖𝗛𝗖 𝗦𝗽𝗿𝗶𝗻𝗴 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲! Make sure to stop by Booth #105. See you on the show floor!

#BioSynexUS #Chembio #NCCHC2026 #NewOrleans

[Chembio Diagnostics, Inc. @ChembioDx]

Improving STI care isn’t just about testing—it’s about supporting what comes next.

Visit https://t.co/SLQPPn0VWf to learn more.

#BioSynexUS #Chembio #STIAwarenessWeek #STIweek #GYT #TalkTestTreat #ClinicalCare #Diagnostics #PublicHealth

[Chembio Diagnostics, Inc. @ChembioDx]

At BioSynex US and Chembio, we support testing with fast, reliable diagnostic insight to help move from results to next steps in care. It’s not just about testing but about driving timely, informed action for every patient.

#BioSynexUS #Chembio #STIAwarenessWeek #TalkTestTreat

[Chembio Diagnostics, Inc. @ChembioDx]

At BioSynex US and Chembio, we are committed to supporting that journey by helping enable access to reliable, timely diagnostic information where care decisions are made.

#BioSynexUS #Chembio #STIAwarenessWeek #GYT #TalkTestTreat #PatientCare #PublicHealth

[Chembio Diagnostics, Inc. @ChembioDx]

Tomorrow is the 2026 Biomedical HIV Prevention Summit! BioSynexUS and Chembio are proud to support public health with rapid, point-of-care diagnostic solutions. Stop by Booth 112 to see our latest infectious disease innovations. See you tomorrow!
#BioSynexUS #Chembio #BHPS2026

[Chembio Diagnostics, Inc. @ChembioDx]

𝗧𝗵𝗲 𝗕𝗶𝗼𝗦𝘆𝗻𝗲𝘅 𝗨𝗦 𝘁𝗲𝗮𝗺 𝗶𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗛𝗲𝗻𝗿𝘆 𝗦𝗰𝗵𝗲𝗶𝗻 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝗮𝗹𝗲𝘀 𝗠𝗲𝗲𝘁𝗶𝗻𝗴, 𝗠𝗮𝗿𝗰𝗵 𝟮𝟲–𝟮𝟴 𝗶𝗻 𝗢𝗿𝗹𝗮𝗻𝗱𝗼. Visit our booth to see how this comes to life across our portfolio!

#BioSynexUS #Chembio #Qualigen #HenryScheinNSM

[Chembio Diagnostics, Inc. @ChembioDx]

We are pleased to announce a new agreement between Qualigen Diagnostics and Afaxys GPO.

Read the full press release here: https://t.co/chUsXkrJAF

#BioSynexUS #Qualigen #WomensHealth #Diagnostics #PublicHealth #FastPackIP

[Chembio Diagnostics, Inc. @ChembioDx]

𝗖𝗮𝘁𝗰𝗵 𝘂𝘀 𝗮𝘁 𝗦𝗬𝗡𝗖 𝟮𝟬𝟮𝟲!

Stop by Table 26 March 18-20 – The BioSynex/Chembio team is ready to discuss how our latest diagnostic solutions are advancing sexual health.

Learn more: https://t.co/wt2IMgnwxt

#BioSynexUS #Chembio #SYNC2026 #PublicHealth #HIVTesting

[Chembio Diagnostics, Inc. @ChembioDx]

We’re on-site this week at the AMSUS Annual Meeting, connecting with military and federal healthcare leaders committed to addressing the ongoing HIV and syphilis epidemic. Visit us at 𝗕𝗼𝗼𝘁𝗵 #𝟭𝟬𝟰.

#BioSynexUS #Chembio #AMSUS2026 #MilitaryMedicine #HIVAwareness #Syphilis